Activation of ROS-PERK-TFEB by filbertone ameliorates neurodegenerative diseases via enhancing the autophagy-lysosomal pathway

J Nutr Biochem. 2023 Aug:118:109325. doi: 10.1016/j.jnutbio.2023.109325. Epub 2023 Mar 22.

Abstract

The molecular mechanisms underlying the pathogenesis of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease (PD), and Huntington's disease remain enigmatic, resulting in an unmet need for therapeutics development. Here, we suggest that filbertone, a key flavor compound found in the fruits of hazel trees of the genus Corylus, can ameliorate PD via lowering the abundance of aggregated α-synuclein. We previously reported that inhibition of hypothalamic inflammation by filbertone is mediated by suppression of nuclear factor kappa-B. Here, we report that filbertone activates PERK through mitochondrial reactive oxygen species production, resulting in the increased nuclear translocation of transcription factor-EB in SH-SY5Y human neuroblastoma cells. TFEB activation by filbertone promotes the autophagy-lysosomal pathway, which in turn alleviates the accumulation of α-synuclein. We also demonstrate that filbertone prevented the loss of dopaminergic neurons in the substantia nigra and striatum of mice on high-fat diet. Filbertone treatment also reduced high-fat diet-induced α-synuclein accumulation through upregulation of the autophagy-lysosomal pathway. In addition, filbertone improved behavioral abnormalities (i.e., latency time to fall and decrease of running distance) in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced PD murine model. In conclusion, filbertone may show promise as a potential therapeutic for neurodegenerative disease.

Keywords: Filbertone; Parkinson's disease; Reactive oxygen species; TFEB; α-Synuclein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autophagy / physiology
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / metabolism
  • Dopaminergic Neurons / metabolism
  • Humans
  • Lysosomes / metabolism
  • Mice
  • Neuroblastoma* / pathology
  • Neurodegenerative Diseases* / drug therapy
  • Neurodegenerative Diseases* / metabolism
  • Parkinson Disease* / drug therapy
  • Reactive Oxygen Species / metabolism
  • alpha-Synuclein / metabolism

Substances

  • alpha-Synuclein
  • 5-methylhept-2-en-4-one
  • Reactive Oxygen Species
  • TFEB protein, human
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors